February 29th 2024
The natural killer cell therapy IDP-023 is being studied in a phase 1 trial for the treatment of patients with non-Hodgkin lymphoma and multiple myeloma.
February 12th 2024
Community Practice Connections™: Real-World Applications of Novel Therapies Across TNBC and Addressing Disparities in Care
6th Annual Precision Medicine Symposium: An Illustrated Tumor Board
October 18-19, 2024
Advances in TNBC: Communicating with Your Patients About Clinical Trial Awareness and Treatment Concerns to Improve Clinical Outcomes
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board